Systemic administration of anti-CD20 indirectly reduces B cells in the inflamed meninges in a chronic model of central nervous system autoimmunity

被引：0
|
作者：
Kerfoot, Steven [1 ]
Tesfagiorgis, Yodit [1 ]
Kemal, Eden A. [1 ]
Craig, Heather C. [1 ]
Parham, Kate A. [1 ]
机构：
[1] Univ Western Ontario, London, ON, Canada
来源：
JOURNAL OF IMMUNOLOGY | 2023年 / 210卷 / 01期
关键词：
D O I：
10.4049/jimmunol.210.Supp.85.05
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [41] The Different Clinical Effects of Anti-BLyS, Anti-APRIL and Anti-CD20 Antibodies Point at a Critical Pathogenic Role of γ-Herpesvirus Infected B Cells in the Marmoset EAE Model
    S. Anwar Jagessar
    Zahra Fagrouch
    Nicole Heijmans
    Jan Bauer
    Jon D. Laman
    Luke Oh
    Thi Migone
    Ernst J. Verschoor
    Bert A. ’t Hart
    Journal of Neuroimmune Pharmacology, 2013, 8 : 727 - 738
  • [42] Inflammatory microenvironment rescues B-Cells of tertiary lymphoid organs from anti-CD20 therapy during chronic antibody-mediated rejection.
    Thaunat, Olivier
    Patey, Natacha
    Gautreau, Chantal
    Nicoletti, Antonino
    AMERICAN JOURNAL OF TRANSPLANTATION, 2008, 8 : 448 - 448
  • [43] Therapeutic zinc aspartate impairs metabolic fitness of CD4+ T Cells and reduces Th1 central nervous system autoimmunity and Th2 asthma
    Krone, A.
    Fu, Y.
    Schreiber, S.
    Kotrba, J.
    Noetzold, A.
    Dudeck, A.
    Reinhold, A.
    Mueller, A.
    Kahlfuss, S.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2022, 52 : 83 - 83
  • [44] B-Cell Depletion Using IgG1 Anti-CD20 Spares MZ B Cells and Promotes Tolerance to Human FVIII In a Murine Model of Hemophilia A.
    Zhang, Al-Hong
    Skupsky, Jonathan
    Scott, David W.
    BLOOD, 2010, 116 (21) : 909 - 909
  • [45] VLA4 expression by B cells enables B cell-restricted antigen presentation to support CD4 T cell driven central nervous system autoimmunity
    Harp, Chelsea R. Parker
    Archambault, Angela S.
    Sim, Julia
    Carrero, Javier A.
    Russell, John
    Wu, Gregory F.
    JOURNAL OF IMMUNOLOGY, 2018, 200 (01):
  • [46] Combined Depletion of B-Cells and T-Cells Using Anti-CD20 Plus Anti-CD3 Is Superior to B-Cell Depletion Alone in Prevention of Recall Responses to HLA-A2 in a Mouse Model of Sensitization.
    Wu, Gordon D.
    Todo, Tsuyoshi
    Chai, Ning-ning
    Wang, Hong
    Klein, Andrew S.
    Jordan, Stanley C.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2009, 9 : 701 - 702
  • [47] The Type II Anti-CD20 Antibody Obinutuzumab (GA101) Is More Effective Than Rituximab at Depleting B Cells and Treating Disease in a Murine Lupus Model
    Marinov, Anthony D.
    Wang, Haowei
    Bastacky, Sheldon I.
    van Puijenbroek, Erwin
    Schindler, Thomas
    Speziale, Dario
    Perro, Mario
    Klein, Christian
    Nickerson, Kevin M.
    Shlomchik, Mark J.
    ARTHRITIS & RHEUMATOLOGY, 2021, 73 (05) : 848 - 857
  • [48] Delivery of an miR155 inhibitor by anti-CD20 single-chain antibody into B cells reduces the acetylcholine receptor-specific autoantibodies and ameliorates experimental autoimmune myasthenia gravis
    Wang, Y. -Z.
    Tian, F. -F.
    Yan, M.
    Zhang, J. -M.
    Liu, Q.
    Lu, J. -Y.
    Zhou, W. -B.
    Yang, H.
    Li, J.
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2014, 176 (02): : 207 - 221
  • [49] TYPE2 ANTI-CD20 ANTIBODIES DO NOT RAPIDLY INTERNALISE FROM THE SURFACE OF B CELLS FROM PATIENTS WITH RHEUMATOID ARTHRITIS AND SYSTEMIC LUPUS ERYTHEMATOSUS AND LYSE THEM MORE EFFICIENTLY THAN RITUXIMAB (TYPE 1 ANTI-20ANTIBODY)
    Reddy, V.
    Cambridge, G.
    Isenberg, D.
    Cragg, M.
    Leandro, M.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 530 - 530
  • [50] Recombinant Human IL-15 Trans-Presentation by B Leukemic Cells from Chronic Lymphocytic Leukemia Induces Autologous NK Cell Proliferation Leading to Improved Anti-CD20 Immunotherapy
    Laprevotte, Emilie
    Voisin, Gregory
    Ysebaert, Loic
    Klein, Christian
    Daugrois, Camille
    Laurent, Guy
    Fournie, Jean-Jacques
    Quillet-Mary, Anne
    JOURNAL OF IMMUNOLOGY, 2013, 191 (07): : 3634 - 3640
12345